Monday, July 16, 2018

Cerapedics Scores $22M For Bone Grafts

Westminster, Colorado-based Cerapedics, a startup developing bone grafts aimed at use in spinal surgery, has raised $22M in funding, the company said on Friday. The funding was led by KCK Group, a family office focused on medical technology. Glen A. Kashuba is CEO of Cerapedics. The company said the new funds go towards a second Level I investigational device exemption (IDE) human clinical study. KCK Group adds three board members to Cerapedics' board as part of the funding: Valeska Schroeder, Ph.D., managing director of the medical technologies division at KCK Group, Greg Garfield, J.D., senior managing director and head of the medical technologies division at KCK Group, and Nael Karim Kassar, investment partner at KCK Group. More information »